Pinnacle Associates LTD Coll Plant Biotechnologies LTD Transaction History
Pinnacle Associates LTD
- $7.15 Billion
- Q3 2025
A detailed history of Pinnacle Associates LTD transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Pinnacle Associates LTD holds 507,193 shares of CLGN stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
507,193
Previous 507,193
-0.0%
Holding current value
$1.01 Million
Previous $689,000
89.11%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CLGN
# of Institutions
22Shares Held
2.29MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC589KShares$1.17 Million0.16% of portfolio
-
Investment Management Of Virginia LLC464KShares$923,1590.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$550,0952.69% of portfolio
-
Amh Equity LTD200KShares$398,0000.73% of portfolio
-
Brown Advisory Inc119KShares$236,2740.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $22.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...